Physician
Eye Disease Consultants, LLC
Eye Disease Consultants, LLC was paid $444K by Medicaid between Jan 2018 and Dec 2024, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoEYE DISEASE CONSULTANTS, LLC
WEST HARTFORD, CT 06107
WEST HARTFORD, CT 06107
33aNPI1487621819assigned 03/03/2006
28Total paid$444K
24GClaims35,683
24DCodes billed31
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,988 | $42K | |
| 2019 | 5,070 | $41K | |
| 2020 | 4,188 | $53K | |
| 2021 | 4,640 | $51K | |
| 2022 | 5,175 | $69K | |
| 2023 | 7,307 | $95K | |
| 2024incomplete | 4,315 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 8,014 | 5,954 | $252K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 15% | 1,232 | 951 | $67K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 7.8% | 1,071 | 848 | $34K |
| 92134 | 7.7% | 2,674 | 2,027 | $34K | |
| 92250 | 5.0% | 846 | 636 | $22K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 3.1% | 310 | 162 | $14K |
| 92020 | 1.4% | 778 | 591 | $6K | |
| 92015 | Determination of refractive state | 1.3% | 244 | 185 | $6K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 222 | 155 | $3K |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 206 | 128 | $2K |
| 92226 | <1% | 236 | 123 | $2K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 44 | 41 | $1K |
19 more codes
| 92083 | <1% | 13 | $430.65 | |
| 76519 | <1% | 45 | $369.76 | |
| 67515 | <1% | 14 | $322.02 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 14 | $38.07 |
| 1036F | <1% | 7,786 | $0.01 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 9,076 | $0.01 |
| 3017F | 0% | 173 | $0.00 | |
| 1111F | 0% | 553 | $0.00 | |
| G8397 | Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy | 0% | 874 | $0.00 |
| G8756 | No documentation of blood pressure measurement, reason not given | 0% | 134 | $0.00 |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 128 | $0.00 |
| 3284F | 0% | 16 | $0.00 | |
| 5010F | 0% | 253 | $0.00 | |
| G8483 | Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) | 0% | 128 | $0.00 |
| 4004F | 0% | 292 | $0.00 | |
| 2022F | 0% | 65 | $0.00 | |
| G9900 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified | 0% | 148 | $0.00 |
| 2027F | 0% | 41 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 53 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAUDIO, PAUL (MANAGING PARTNER)